Shares of United-Guardian, Inc. (NASDAQ:UG) have been assigned an average rating of “Buy” from the one research firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a buy recommendation.

Separately, ValuEngine upgraded shares of United-Guardian from a “hold” rating to a “buy” rating in a research note on Friday.

United-Guardian stock traded down $0.22 during mid-day trading on Tuesday, reaching $19.43. 454 shares of the company traded hands, compared to its average volume of 3,833. United-Guardian has a fifty-two week low of $17.74 and a fifty-two week high of $20.89. The company has a market capitalization of $89.26 million, a price-to-earnings ratio of 22.41 and a beta of -0.27. The firm’s fifty day moving average is $19.79 and its two-hundred day moving average is $19.35.

United-Guardian (NASDAQ:UG) last issued its quarterly earnings results on Friday, November 8th. The company reported $0.23 earnings per share (EPS) for the quarter. United-Guardian had a net margin of 31.01% and a return on equity of 34.74%. The business had revenue of $3.32 million for the quarter.

A number of institutional investors have recently modified their holdings of UG. Morgan Stanley increased its stake in shares of United-Guardian by 216.1% in the second quarter. Morgan Stanley now owns 9,707 shares of the company’s stock worth $182,000 after acquiring an additional 6,636 shares during the period. BlackRock Inc. increased its stake in shares of United-Guardian by 8.7% in the second quarter. BlackRock Inc. now owns 25,397 shares of the company’s stock worth $478,000 after acquiring an additional 2,039 shares during the period. Finally, Renaissance Technologies LLC increased its stake in shares of United-Guardian by 2.3% in the second quarter. Renaissance Technologies LLC now owns 262,800 shares of the company’s stock worth $4,941,000 after acquiring an additional 5,800 shares during the period. Institutional investors and hedge funds own 26.54% of the company’s stock.

About United-Guardian

United-Guardian, Inc manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products, and specialty industrial products in the United States and internationally. It offers personal care products, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL II XD; ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics; LUBRASLIDE and B-122 powdered lubricants for use in the manufacture of pressed powders, eyeliners, and rouges; KLENSOFT, a surfactant for use in shampoos, shower gels, makeup removers, and other cosmetic formulations; and LUBRASIL, a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base.

Featured Story: Why do earnings reports matter?

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with's FREE daily email newsletter.